Hongqi Xue, Georg Ferber, Ellen Freebern, Borje Darpo
{"title":"使用浓度- qtc分析方法确定心电动力学心电图评估的样本量。","authors":"Hongqi Xue, Georg Ferber, Ellen Freebern, Borje Darpo","doi":"10.1007/s10928-025-09998-z","DOIUrl":null,"url":null,"abstract":"<p><p>Concentration-QTc (C-QTc) analysis was accepted to serve as an alternative to the by-time point analysis with intersection-union test (IUT) as the primary basis for decisions to classify the arrhythmogenic risk of a drug by ICH E14 Q&As (R3) in December 2015. Since then, this analysis method has been widely applied by industry as it significantly reduces the sample size to achieve the same power as with IUT. There are many model-based power calculation approaches available for C-QTc through simulation in the literature, however, there is still no standard method with a clear formula to determine the sample size for C-QTc analysis to exclude a small effect on the QTc interval. The current model-based simulation approaches are too complicated to prevent them from being widely used, which is not commensurate with the popular status. We have developed a systematic method based on t-tests to determine the sample size for different study designs using the C-QTc analysis method and applied it to many studies. The results of the sample sizes utilizing this method are consistent with simulation studies and validated by real analyses.</p>","PeriodicalId":16851,"journal":{"name":"Journal of Pharmacokinetics and Pharmacodynamics","volume":"52 5","pages":"48"},"PeriodicalIF":2.8000,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sample size determination for cardiodynamic ECG assessment using the Concentration-QTc analysis method.\",\"authors\":\"Hongqi Xue, Georg Ferber, Ellen Freebern, Borje Darpo\",\"doi\":\"10.1007/s10928-025-09998-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Concentration-QTc (C-QTc) analysis was accepted to serve as an alternative to the by-time point analysis with intersection-union test (IUT) as the primary basis for decisions to classify the arrhythmogenic risk of a drug by ICH E14 Q&As (R3) in December 2015. Since then, this analysis method has been widely applied by industry as it significantly reduces the sample size to achieve the same power as with IUT. There are many model-based power calculation approaches available for C-QTc through simulation in the literature, however, there is still no standard method with a clear formula to determine the sample size for C-QTc analysis to exclude a small effect on the QTc interval. The current model-based simulation approaches are too complicated to prevent them from being widely used, which is not commensurate with the popular status. We have developed a systematic method based on t-tests to determine the sample size for different study designs using the C-QTc analysis method and applied it to many studies. The results of the sample sizes utilizing this method are consistent with simulation studies and validated by real analyses.</p>\",\"PeriodicalId\":16851,\"journal\":{\"name\":\"Journal of Pharmacokinetics and Pharmacodynamics\",\"volume\":\"52 5\",\"pages\":\"48\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-08-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmacokinetics and Pharmacodynamics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s10928-025-09998-z\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacokinetics and Pharmacodynamics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10928-025-09998-z","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Sample size determination for cardiodynamic ECG assessment using the Concentration-QTc analysis method.
Concentration-QTc (C-QTc) analysis was accepted to serve as an alternative to the by-time point analysis with intersection-union test (IUT) as the primary basis for decisions to classify the arrhythmogenic risk of a drug by ICH E14 Q&As (R3) in December 2015. Since then, this analysis method has been widely applied by industry as it significantly reduces the sample size to achieve the same power as with IUT. There are many model-based power calculation approaches available for C-QTc through simulation in the literature, however, there is still no standard method with a clear formula to determine the sample size for C-QTc analysis to exclude a small effect on the QTc interval. The current model-based simulation approaches are too complicated to prevent them from being widely used, which is not commensurate with the popular status. We have developed a systematic method based on t-tests to determine the sample size for different study designs using the C-QTc analysis method and applied it to many studies. The results of the sample sizes utilizing this method are consistent with simulation studies and validated by real analyses.
期刊介绍:
Broadly speaking, the Journal of Pharmacokinetics and Pharmacodynamics covers the area of pharmacometrics. The journal is devoted to illustrating the importance of pharmacokinetics, pharmacodynamics, and pharmacometrics in drug development, clinical care, and the understanding of drug action. The journal publishes on a variety of topics related to pharmacometrics, including, but not limited to, clinical, experimental, and theoretical papers examining the kinetics of drug disposition and effects of drug action in humans, animals, in vitro, or in silico; modeling and simulation methodology, including optimal design; precision medicine; systems pharmacology; and mathematical pharmacology (including computational biology, bioengineering, and biophysics related to pharmacology, pharmacokinetics, orpharmacodynamics). Clinical papers that include population pharmacokinetic-pharmacodynamic relationships are welcome. The journal actively invites and promotes up-and-coming areas of pharmacometric research, such as real-world evidence, quality of life analyses, and artificial intelligence. The Journal of Pharmacokinetics and Pharmacodynamics is an official journal of the International Society of Pharmacometrics.